Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats

Peptides

Volumn 21, Issue 7, 2000, Pages 1125-1130

  Di Giannuario, Amalia ^a   Pieretti, Stefano ^a  

^a Laboratorio di Farmacologia   (Italy)

Author keywords

Accumbens; Caudate; Dopamine; Microdialysis; Nociceptin; Orphanin; Rats; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALCOHOL; DOPAMINE; HOMOVANILLIC ACID; MORPHINE; NOCICEPTIN;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONDITIONING; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG ABUSE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALGESICS, OPIOID; ANIMALS; CAUDATE NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMISTRY; ETHANOL; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; MORPHINE; NUCLEUS ACCUMBENS; OPIOID PEPTIDES; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 0033821874     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00250-3     Document Type: Article

References (50)

1. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL1 in the central nervous system of the rat. J Comp Neurol. 368:1996;229-251.
2. Betto P., Popoli P., Ricciarello G., Caporali M.G., Antonini R. Simultaneous high-performance liquid chromatographic determination of adenosine and dopamine in rat striatal tissue with combined ultraviolet absorbance and electrochemical detection. J Chromatogr B. 662:1994;21-25.
3. Bunzow J.R., Saez C., Mortrud M., et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ δ or k receptor type. FEBS Lett. 347:1994;284-288.
4. Champion HC, Kadowitz PJ. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypothensive activity in the rat. Life Sci 197;60:PL241-PL245.
5. Ciccocioppo R., Panocka I., Polidori C., Regoli D., Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology. 141:1999;220-224.
6. 2+ in the SH-SY5Y human neuroblastoma cell line. Br J Pharmacol. 118:1996;205-207.
7. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol. 119:1996;1614-1618.
8. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release in vivo microdialysis studies . J Pharmacol Exp Ther. 266:1993;1236-1246.
9. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonist on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther. 244:1988;1067-1080.
10. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol. 12:1998;54-67.
11. Di Giannuario A., Pieretti S., Catalani A., Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens a microdialysis study in rats . Neurosci. Lett. 272:1999;183-186.
12. Enrico P., Mura M.A., Esposito G., et al. Effects of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Brain Res. 797:1998;94-102.
13. Grant S.J., Sonti G. Buprenorphine and morphine produce equivalent increase in extracellular single unit activity of dopamine neurons in the ventral tegmental area in vivo. Synapse. 16:1994;181-187.
14. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 277:1983;119-127.
15. Heleyes Z., Nemeth J., Pinter E., Szolesànyi J. Inhibition by nociceptin of neurogenic inflammation and release of SP and CGRP from sensory nerve terminals. Br J Pharmacol. 121:1997;613-615.
16. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand -nociceptin/orphanin FQ. Trends Pharmacol Sci. 18:1997;293-300.
17. Herz A., Shippenberg T.S. Neurochemical aspects of addiction opioids and other drugs of abuse . Goldstein A. Molecular and cellular aspects of the drug addictions. 1989;111-141 Springer-Verlag, New York.
18. Iwatsubo K., Clouet D.H. Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons. J Pharmacol Exp Ther. 202:1977;429-436.
19. Jenk F., Moreau J.-L., Martin J.R., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci. 94:1997;14854-14858.
20. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 12:1992;483-489.
21. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodentritic dopamine release in the ventral tegmental area by opioids and GABA an in vivo microdialysis study . J Neurosci. 12:1992;2623-2632.
22. Knoflach F., Reinscheid R.K., Civelli O., Kemp J. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J Neurosci. 16:1996;6657-6664.
23. Konya H., Masuda H., Itoh K., Nagai K., Kakishita E., Matsuoka A. Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res. 788:1998;341-344.
24. 2 on ethanol intake and ethanol-induced conditioned place preference (CPP) in alcohol-preferring rats. Regul Pept. 80:1999;125.
25. Matthews R.T., German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience. 11:1984;617-628.
26. Meunier J.-C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
27. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
28. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antgonism of μ- δ- and k-opioid antinociception by orphanin FQ. Neurosci Lett. 214:1996;131-134.
29. Murphy N.P., Ly H.T., Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anesthetized rats. Neuroscience. 75:1996;1-4.
30. Murphy N.P., Maidment N.T. Orphanin FQ/Nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem. 73:1999;179-186.
31. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
32. Neal M.J., Cunningham J.R., Paterson S.J., McKnight A.T. Inhibition by nociceptin of the light-evoked release of Ach from retinal cholinergic neurones. Br J Pharmacol. 120:1997;1399-1400.
33. Okuda-Ashitaka E., Tachibana S., Houtani T., et al. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C its involvement in allodynic response to innocuous stimulus . Mol. Brain Res. 43:1996;96-104.
34. Patel H.J., Geimbycz M.A., Spicuzza L., Barnes P.J., Belvisi M.G. Naloxone-insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea pig trachea by the novel opioid, nociceptin. Br J Pharmacol. 120:1997;735-736.
35. Paxinos G., Watson C. The rat brain in Stereotaxic coordinates. Compact 3rd edition CD-Rom. 1996;Academic Press, San Diego.
36. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport. 8:1996;369-371.
37. Reinscheid R.K., Nothacker H.-P., Bourson A., et al. Orphanin FQ a neuropeptide that activates an opioid-like G protein-coupled receptor . Science. 270:1995;792-794.
38. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Ternius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9:1997;194-197.
39. Schilcker E., Werthwein S., Kathmann M., Bauer U. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedebergs Arch Pharmacol. 358:1998;418-422.
40. Spanagel R., Herz A., Shippenberg T.S. Identification of the opioid receptor types mediating β-endorphin-induced altrations in dopamine release in the nucleus accumbens. Eur J Pharmacol. 190:1990;177-184.
41. Spanagel R., Herz A., Shippenberg T.S. The Effects of opioid peptides on dopamine release in the nucleus accumbens. An in vivo microdialysis study. J Neurochem. 55:1990;1734-1740.
42. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid system modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA. 89:1992;2046-2050.
43. Standifer K.M., Pasternak G.W. G proteins and opioid receptor-mediated signalling. Cell Signal. 9:1997;237-248.
44. + conductance in dorsal raphe nucleus neurones. Br J Pharmacol. 117:1996;1609-1611.
45. 1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci. 17:1997;996-1003.
46. Werthwein S., Bauer U., Nakazi M., Kathmann M., Schlicker E. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. Br J Pharmacol. 127:1999;300-308.
47. Wood P.L. Interrelationships of opioid, dopaminergic, cholinergic, and GABAergic pathways in the central nervous system. Herz A. Handbook of experimental pharmacology, Vol. 104/I. 1993;625-643 Springer-Verlag Berlin, Heidelberg.
48. Yoshida Y., Koide S., Hirose N., et al. Fentanyl increases dopamine release in rat nucleus accumbens involvement of mesolimbic μ- and δ-2-opioid receptors . Neuroscience. 92:1999;1357-1365.
49. Yu T.P., Fein J., Phan T., Evans C.J., Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
50. Zaratin P., Clarke G.D. Comparative effects of selective k-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats. Eur J Pharmacol. 264:1994;151-156.